Insider trading

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,041 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,041 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,041 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,041 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,041 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,041 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,041 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
12 Mar 2026
SONNE STEPHEN CHIEF LEGAL OFFICER
Sold at will
$51.36K 6,802 at 7.55
3.2%
Not planned
12 Mar 2026
Fitzgerald Lindsay Clinton Chief Public Affairs Officer
Sold on a plan
$50.12K 20,000 at 2.51
8.6%
Planned (10b5-1)
12 Mar 2026
ROMNEY RONNA Director
Sold at will 2×
$49.02K 2,000 at 24.51
6.9%
Not planned
12 Mar 2026
Klein James D. President, CRBT
Sold at will
$45.71K 554 at 82.50
42.9%
Not planned
12 Mar 2026
Sold at will
$42.83K 3,766 at 11.37
100%
Sold half or more
12 Mar 2026
Sold on a plan
$35.69K 260 at 137.25
2.7%
Planned (10b5-1)
12 Mar 2026
Coletta Edmond PRESIDENT & CEO
Sold on a plan
$33.85K 377 at 89.80
0.2%
Planned (10b5-1)
12 Mar 2026
FIELDS RANDALL K CHIEF EXECUTIVE OFFICER · indirect
Sold on a plan
$32.24K 4,000 at 8.06
4.5%
Planned (10b5-1)
12 Mar 2026
YOUNT SAMUEL Chief Business Officer · indirect
Sold at will 2×
$31.94K 3,011 at 10.61
1.5%
Not planned
12 Mar 2026
Russotti Gregory See Remarks
Sold at will
$25.68K 10,076 at 2.55
1.9%
Not planned
12 Mar 2026
Remer Eric Richard Chief Executive Officer
Sold on a plan
$22.73K 1,874 at 12.13
0.1%
Planned (10b5-1)
12 Mar 2026
Sold on a plan
$19.45K 75 at 259.33
4.1%
Planned (10b5-1)
12 Mar 2026
PARRISH JESSICA L VP, Chief Accounting Officer
Sold on a plan
$18.41K 47 at 391.69
1.4%
Planned (10b5-1)
12 Mar 2026
Carr Douglas SVP Finance & Operations
Sold at will
$17.95K 7,043 at 2.55
1.4%
Not planned
12 Mar 2026
Doellinger Chad J Chief Legal & Admin. Officer
Sold on a plan
$15.09K 116 at 130.06
0.3%
Planned (10b5-1)
12 Mar 2026
International Finance Corp 10% owner · indirect
Sold at will
$13.28K 2,839 at 4.68
0.0%
Not planned
12 Mar 2026
Park Jaehyun Chief Financial Officer
Sold at will
$12.37K 958 at 12.91
100%
Sold half or more
12 Mar 2026
Sayward Shelley E. SENIOR VP & GENERAL COUNSEL
Sold on a plan
$11.57K 129 at 89.71
0.4%
Planned (10b5-1)
12 Mar 2026
Reppas Tiah Norton Chief Accounting Officer
Sold at will
$10.06K 6,250 at 1.61
33.5%
Not planned
12 Mar 2026
Sold at will
$9.30K 1,002 at 9.28
0.2%
Not planned
12 Mar 2026
Steves Sean Sr VP & COO of SW Ops
Sold on a plan
$8.70K 97 at 89.71
1.0%
Planned (10b5-1)
12 Mar 2026
Maltezos Louis P President-Central&West USA Can
Sold on a plan
$7.74K 306 at 25.31
0.9%
Planned (10b5-1)
12 Mar 2026
SCHULMAN AMY W Director
Sold at will
$7.48K 26 at 287.50
10.7%
Not planned
12 Mar 2026
Devlin Jodi Chief of Clinical Operations
Sold at will
$7.25K 1,772 at 4.09
1.8%
Not planned
12 Mar 2026
Chiplock Mark EVP, CFO & CAO
Sold on a plan
$6.91K 273 at 25.31
14.1%
Planned (10b5-1)
12 Mar 2026
Marshak Richard Chief Commercial Officer
Sold at will
$6.50K 1,589 at 4.09
1.4%
Not planned
12 Mar 2026
Stevens Jennifer Chief Regulatory Officer
Sold at will
$6.35K 1,552 at 4.09
1.2%
Not planned
12 Mar 2026
Cox Bryan F. Chief of Research
Sold at will
$6.00K 1,467 at 4.09
0.9%
Not planned
12 Mar 2026
Drohan Kevin VP & CHIEF ACCOUNTING OFFICER
Sold on a plan
$4.92K 55 at 89.52
0.7%
Planned (10b5-1)
12 Mar 2026
Kehler Dean C Director · indirect
Sold at will
$4.40K 500 at 8.80
0.4%
Not planned
12 Mar 2026
Uczekaj John President and COO
Sold at will
$4.13K 396 at 10.43
1.7%
Not planned
12 Mar 2026
Duhay Francis Director
Sold on a plan
$1.61K 140 at 11.52
5.3%
Planned (10b5-1)
12 Mar 2026
Sold at will
$1.33K 7 at 190.00
0.4%
Not planned
12 Mar 2026
Arnett Austin General Counsel
Sold at will
$1.25K 247 at 5.08
8.4%
Not planned
12 Mar 2026
Christianson Mark Business Development Director
Sold at will
$653.60 817 at 0.80
0.4%
Not planned
12 Mar 2026
Corrsin David J EVP and General Counsel · indirect
Sold on a plan
$480.89 19 at 25.31
4.1%
Planned (10b5-1)
12 Mar 2026
Sparrow Dean Chad Director · indirect
Sold at will
$28.32 6 at 4.72
5.2%
Not planned
12 Mar 2026
PERNICE THOMAS J Director
Sold on a plan
no price 25,000 shares
12.5%
Planned (10b5-1)
11 Mar 2026
Sold at will 3×
$172.08M 1,389,792 at 123.82
0.3%
Not planned
11 Mar 2026
Sold at will
$35.12M 838,000 at 41.91
3.2%
Not planned
11 Mar 2026
Foroughi Arash Adam CEO & Chairperson
Sold at will 24×
$23.30M 50,000 at 466.04
2.0%
Not planned
11 Mar 2026
Simonelli Lorenzo Chairman, President and CEO
Sold on a plan
$16.03M 272,594 at 58.79
23.9%
Planned (10b5-1)
11 Mar 2026
Quinn William J Director · indirect
Sold at will
$15.32M 800,000 at 19.15
9.7%
Not planned
11 Mar 2026
MURDOCH LACHLAN K Executive Chair, CEO
Sold on a plan 2×
$14.02M 242,747 at 57.74
58.0%
Sold half or more
11 Mar 2026
NALLEN JOHN President, COO
Sold on a plan 2×
$13.99M 242,309 at 57.74
40.4%
Planned (10b5-1)
11 Mar 2026
Liberman Paul See Remarks · indirect
Sold on a plan 2×
$12.19M 484,417 at 25.16
69.4%
Sold half or more
11 Mar 2026
NOVAKOVIC PHEBE N Chairman and CEO
Sold at will 2×
$11.66M 32,918 at 354.09
4.1%
Not planned
11 Mar 2026
VINCIARELLI PATRIZIO Chairman and CEO
Sold on a plan 11×
$8.87M 50,000 at 177.41
0.5%
Planned (10b5-1)
11 Mar 2026
ROBINS HARLAN S Chief Scientific Officer
Sold at will 2×
$6.19M 470,266 at 13.17
23.6%
Not planned
11 Mar 2026
ROBINS CHAD M CEO and Chairman
Sold at will 2×
$6.19M 470,167 at 13.17
17.0%
Not planned
Showing 27,551–27,600 of 46,041. ← Newer Page 552 of 921 Older →